03669nam 2200649 450 991079399940332120210227085428.01-5261-3037-810.7765/9781526130372(CKB)4100000009076112(OCoLC)1132665216(MdBmJHUP)muse78013(MiAaPQ)EBC6371017(DE-B1597)659105(DE-B1597)9781526130372(EXLCZ)99410000000907611220210227d2009 uy 0engur|||||||nn|ntxtrdacontentcrdamediacrrdacarrierIdentities, discourses and experiences young people of North African origin in France /Nadia KiwanManchester, England :Manchester University Press,[2009]©20091 online resource (262 p. :)ill., map ;0-7190-7688-9 0-7190-9119-5 Includes bibliographical references (p. [223]-242) and index.Nation, immigration, integration: the public debates of the 1980s, 1990s and twenty-first century -- 'Cultural difference', citizenship and young people: intellectual responses -- An alternative approach to post-migrant narratives? -- Individualist trajectories: social worlds and cultural positionings -- Collective identities and cultural communities? -- The socio-economics of community -- Subjective identities -- From individual to collective subjectivities?The 2005 rioting in France's suburbs caught the world's attention and exposed the limits of the Republic's policies on the integration of 'immigrant-origin' populations.This book examines academic and public discourses about young people of North African origin in France. The resurgence of such discussions in France, focusing on sensational questions of urban unrest, Islamic fundamentalism and the challenges of increasingly assertive cultural identities, means that it is all the more necessary not to overlook the 'ordinary' majority of young French-North Africans. Their own preoccupations often go unnoticed in a context where issues such as violence in the banlieues and the threat of terrorism are pushed to the fore, sometimes with devastating consequences in terms of discrimination and exclusion.The book rebalances and nuances the debates about post-migrant North-African youth by drawing on extensive empirical research carried out in those suburbs of north-east Paris affected by the riots. It studies the construction of identity amongst this invisible majority and, by adopting an ethnographic approach, addresses the disjuncture between the sometimes inflammatory discourses about this population and their own experiences.North AfricansFranceEthnic identityFrankreichswdNordafrikanerswdNordafrikaswdFrance.Muslim origin.North African immigrants.bottom-up approach.collective identity.cultural experience.descendants.individual identity.post-migrant discourses.socio-economic experience.subjective identities.young people.North AfricansEthnic identity.305.2308992761044Kiwan Nadia1103693MiAaPQMiAaPQMiAaPQBOOK9910793999403321Identities, discourses and experiences3694367UNINA04701nam 2200601Ia 450 991079020920332120200520144314.01-61761-167-0(CKB)2670000000150170(EBL)3017989(SSID)ssj0000694155(PQKBManifestationID)11368968(PQKBTitleCode)TC0000694155(PQKBWorkID)10667230(PQKB)11551206(MiAaPQ)EBC3017989(Au-PeEL)EBL3017989(CaPaEBR)ebr10658911(OCoLC)775352327(EXLCZ)99267000000015017020100625d2011 uy 0engur|n|---|||||txtccrVentricular fibrillation and acute coronary syndrome[electronic resource] /editor, Joyce E. MandellHauppauge, NY Nova Science20111 online resource (248 p.)Cardiology research and clinical developmentsDescription based upon print version of record.1-61728-969-8 Includes bibliographical references and index.""VENTRICULAR FIBRILLATION AND ACUTE CORONARY SYNDROME""; ""VENTRICULAR FIBRILLATION AND ACUTE CORONARY SYNDROME""; ""CONTENTS ""; ""PREFACE""; ""CLOPIDOGREL RESPONSE IN ACUTE CORONARY SYNDROME: CLINICAL IMPLICATIONS AND EMERGING THERAPIES ""; ""ABSTRACT ""; ""ABBREVIATIONS LIST ""; ""INTRODUCTION ""; ""RESISTANCE/VARIABLE RESPONSE TO CLOPIDOGREL. DOES IT EXIST? ""; ""MECHANISMS OF VARIABLE RESPONSE TO CLOPIDOGREL ""; ""Genetic Polymorphism ""; ""Drug-Drug Interactions ""; ""Statins ""; ""Proton Pump Inhibitors ""; ""Calcium-Channel Blockers """"IS IT POSSIBLE TO ACCURATELY ASSESS THE INHIBITORY EFFECT OF ANTIPLATELT DRUGS? """"CLINICAL IMPLICATIONS OF VARIABLE RESPONSE TO CLOPIDOGREL ""; ""Drug Eluting Stent""; ""WHAT TO DO WITH PATIENTS WITH REDUCED RESPONSE TO CLOPIDOGREL THERAPY? ""; ""Optimise Clopidogrel Response According to Platelet Function Tests ""; ""EMERGING THERAPIES ""; ""Prasugrel ""; ""Ticagrelor ""; ""Cangrelor ""; ""REFERENCES ""; ""PROTEOMICS OF ACUTE CORONARY SYNDROME ""; ""1. INTRODUCTION ""; ""2. PLASMA ""; ""3. BLOOD CELLS IN ACUTE CORONARY SYNDROME ""; ""3.1. Circulating Monocytes ""; ""3.2 Platelets """"3.3. Proteomics on Vascular Progenitors """"Endothelial Progenitor Cells (EPC) ""; ""4. TISSUE PROTEOMICS ""; ""Secretome ""; ""5. METABOLOMICS""; ""ABBREVIATIONS""; ""PROTEINS ABBREVIATIONS ""; ""REFERENCES ""; ""MAJOR BLEEDING IN ACUTE CORONARY SYNDROME: DEFINITIONS, MAGNITUDE OF THE PROBLEM, PREDICTORS, OUTCOMES, MANAGEMENT, AND PREVENTION ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""DEFINITIONS OF MAJOR BLEEDING IN ACS ""; ""MAGNITUDE OF THE PROBLEM ""; ""PREDICTORS OF MAJOR BLEEDING ""; ""Age ""; ""Gender ""; ""History of Bleeding ""; ""Renal Impairment ""; ""Type of ACS """"Killip Class """"Diabetes Mellitus ""; ""Choice of Antiplatelet, Antithrombotic, and Fibrinolytic Agents""; ""Invasive Procedures ""; ""Blood Transfusion ""; ""Anemia ""; ""HOSPITAL OUTCOMES AND MAJOR BLEEDING ""; ""Mechanisms by Which Major Bleeding Affects Outcomes ""; ""Prevention and Management ""; ""CONCLUSION ""; ""REFERENCES""; ""NOVEL ANTIPLATELETS IN ACUTE CORONARY SYNDROMES ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""ASPIRIN (ACETYLSALICYLIC ACID, ASA) ""; ""THIENOPYRIDINES ""; ""Ticlopidine ""; ""Clopidogrel ""; ""Prasugrel ""; ""Cangrelor (ARC-69931MX) ""; ""Ticagrelor (AZD6140) """"Elinogrel """"Bx667 ""; ""THROMBOXANE RECEPTOR ANTAGONISTS ""; ""Terutroban (S18886) ""; ""von Willebrand Factor Inhibitors ""; ""Ajw200 ""; ""Arc1779 ""; ""Alx-0081 ""; ""DIRECT THROMBIN INHIBITORS (PAR-1 INHIBITORS) ""; ""Sch 530348 ""; ""E5555 ""; ""CONCLUSION ""; ""REFERENCES ""; ""UNCONTROLLED IMMUNE RESPONSE IN ACUTE MYOCARDIAL INFARCTION ""; ""ABSTRACT""; ""INTRODUCTION ""; ""LEUKOCYTES ""; ""NEUTROPHILS ""; ""MONOCYTES ""; ""LYMPHOCYTES ""; ""Rationale and Clinical Evidence ""; ""Effector T-Cells ""; ""Regulatory T-Cells ""; ""The Inverted Pyramid Model """"THERAPEUTIC OPPORTUNITIES ""Cardiology research and clinical developments.Coronary heart diseaseVentricular fibrillationCoronary heart disease.Ventricular fibrillation.616.1/23Mandell Joyce E1573467MiAaPQMiAaPQMiAaPQBOOK9910790209203321Ventricular fibrillation and acute coronary syndrome3849226UNINA